Start |Forschung|Abteilungen / AGs / Institute|Abhängiges Verhalten und Suchtmedizin|Arbeitsgruppen|AG Neuroenhancement|Publikationen

Publikationen: Neuroenhancement

Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study. Transl Psychiatry. 2026 16(1):226. Epub 2026 Mar 31.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Association of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study. Lancet Psychiatry. 2026 13(8):669-677.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study. Lancet Reg Health Eur. 2026 65:101658.
Motka F, Tan H, Levine SM, Vollstädt-Klein S, Danböck SK, Bertsch K, Winkler MH, Wittekind CE. Appetitive responses toward smoking-related stimuli in abstinence-motivated, non-deprived individuals with chronic tobacco dependence: A multi-methodological investigation. Addiction. 2026 121(5):1140-1152. Epub 2025 Dec 14.
Rötzer L, Zaiser J, Hoffmann S, Hiß I, Reinhard I, Heim C, Tost H, Kiefer F, Lenz B, Bach P. Sex-Moderated and Sex-Specific Effects of Adverse Childhood Experiences on Neural Alcohol Cue Reactivity and Daily Craving in Individuals With Alcohol Use Disorder. Am J Psychiatry. 2026 Sep 9. [Epub ahead of print]


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de